Mitochondrial and NAD+ metabolism predict recovery from acute kidney injury in a diverse mouse population

Jean-David Morel,Maroun Bou Sleiman,Terytty Yang Li,Giacomo von Alvensleben,Alexis M. Bachmann,Dina Hofer,Ellen Broeckx,Jing Ying Ma,Vinicius Carreira,Tao Chen,Nabil Azhar,Romer A. Gonzalez-Villalobos,Matthew Breyer,Dermot Reilly,Shannon Mullican,Johan Auwerx
DOI: https://doi.org/10.1172/jci.insight.164626
IF: 9.4958
2023-02-09
JCI Insight
Abstract:Acute kidney failure and chronic kidney disease are global health issues steadily rising in incidence and prevalence. Animal models on a single genetic background have so far failed to recapitulate the clinical presentation of human nephropathies. Here, we used a simple model of folic acid–induced kidney injury in 7 highly diverse mouse strains. We measured plasma and urine parameters, as well as renal histopathology and mRNA expression data, at 1, 2, and 6 weeks after injury, covering the early recovery and long-term remission. We observed an extensive strain-specific response ranging from complete resistance of the CAST/EiJ to high sensitivity of the C57BL/6J, DBA/2J, and PWK/PhJ strains. In susceptible strains, the severe early kidney injury was accompanied by the induction of mitochondrial stress response (MSR) genes and the attenuation of NAD + synthesis pathways. This is associated with delayed healing and a prolonged inflammatory and adaptive immune response 6 weeks after insult, heralding a transition to chronic kidney disease. Through a thorough comparison of the transcriptomic response in mouse and human disease, we show that critical metabolic gene alterations were shared across species, and we highlight the PWK/PhJ strain as an emergent model of transition from acute kidney injury to chronic disease.
medicine, research & experimental
What problem does this paper attempt to address?